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Background: Valvular aortic stenosis is a common disease in the elderly, often in multimorbid 
patients. It is often associated with coronary artery disease and peripheral artery disease. In this 
situation, the risk of conventional open-heart surgery is too high, and other treatment strategies 
have to be evaluated.
Case report: A 79-year-old female patient with severe aortic stenosis, coronary artery d  isease 
and end-stage chronic obstructive pulmonary disease suffering from dyspnea at rest and 
p  ermanently dependent on oxygen was treated in three steps. Firstly, her pulmonary infection 
was treated with antibiotics for 7 days. Then, the left anterior descending artery was stented 
(bare-metal stent). In the same session, valvuloplasty of the aortic valve was performed. She 
was sent to rehabilitation to improve her pulmonary condition and took clopidogrel for 4 weeks. 
Finally, she underwent transapical aortic valve replacement. She was released to rehabilitation 
on postoperative day 12.
Conclusion: A combination of modern interventional and minimally invasive surgical tech-
niques to treat aortic stenosis and coronary heart disease can be a viable option for multimorbid 
patients with extremely high risk in conventional open-heart surgery.
Keywords: aortic stenosis, transapical aortic valve replacement, minimally invasive cardiac 
surgery
Introduction
Severe aortic stenosis can only be treated adequately with some form of aortic valve 
replacement, either conventionally with a median (or partial) sternotomy and open-heart 
surgery, with a minimally invasive left thoracotomy on the beating heart (transapical), 
or via access over the peripheral vessels (transfemoral/transaxillary) without opening 
the chest at all.1–3 Sometimes, patients with aortic stenosis also have severe concomi-
tant diseases which dramatically increase the risk of the standard surgical procedures. 
Treating these patients requires a multidisciplinary approach with a combination of 
procedures that are performed one after another.
Case report
We report on a 79-year-old female patient who presented with dyspnea at rest (New 
York Heart Association IV) and chest pain. She had a history of smoking (63 pack 
years) and end-stage chronic obstructive pulmonary disease with a forced expiratory 
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volume in 1 second (FEV1) at admittance of 0.64 L and 
saturation at rest of 72%. She took steroids orally, inhaled 
tiotropium bromide, steroids, and β2-mimetics and had an 
indication for long-term oxygen therapy.
Echocardiography revealed severe aortic stenosis with 
an effective orifice area of 0.3 cm2, a mean gradient of 
50 mmHg, and mitral regurgitation of II°. Ejection fraction 
was not impaired. Heart catheterization was performed 
because of a positive troponin test and showed coronary 
heart disease with stenoses in all three main vessels. The left 
anterior descending artery (LAD) was the biggest coronary 
artery, filling the chronically occluded right coronary artery 
retrograde. The circumflex artery was small. Computed 
tomography angiography revealed severe calcifications 
around the aortic arch and along the whole thoracic and 
abdominal aorta down to the femoral arteries which were 
only 6.5 mm in diameter (Figure 1). The patient had had 
thromboendarterectomy of the left internal carotid artery 
in 2003 and had a moderate stenosis of the right (,70%). 
At admission, she was also suffering from pneumonia. Under 
these conditions, our anesthesiologists decided to postpone 
the aortic valve replacement surgery as she would not have 
been able to tolerate general anesthesia. A multidisciplinary 
approach was scheduled. Firstly, her infection was treated 
with antibiotics (tazobactam + piperacillin) for 7 days until 
leukocytes and C-reactive protein (CRP) normalized. Then we 
performed the first interventional step: the patient underwent 
cardiac catheterization and the LAD, which was the patient’s 
largest and most important coronary artery, was dilated and a 
bare-metal stent was placed. The circumflex artery was small, 
and the right coronary artery was chronically occluded after 
myocardial infarction. In the same session, valvuloplasty of the 
aortic valve was performed successfully without neurological 
complications and a resulting effective orifice area of 0.9 cm2. 
After that, the patient was almost symptom-free but had aortic 
insufficiency of II°. She was sent to rehabilitation to improve 
her pulmonary condition and took clopidogrel for 4 weeks 
because of the new bare-metal stent (600 mg loading dose, 
followed by 75 mg daily). At re-admission, lung function tests 
were repeated and showed an improved FEV1 with 1.33 L. She 
was now in a better condition to   tolerate general ane  sthesia, 
so we performed a transapical aortic valve replacement 
(Edwards SAPIEN Ø 26 mm; Edwards Lifesciences, Irvine, 
CA) using a left mini-thoracotomy2 in our hybrid-operating 
room with a heart-lung machine on standby.
The patient was weaned from the ventilator on the same 
day. She was in sinus rhythm, had no neurological symp-
toms, no dyspnea, and could be released to rehabilitation 
on postoperative day 12. The patient was fine at 6-month 
follow-up.
Discussion
Regarding the coronary disease of our patient, we limited 
revascularization to the LAD, as the circumflex artery was 
small and the right coronary artery chronically occluded after 
myocardial infarction. A bare-metal stent was chosen over 
a drug-eluting stent because double anti-platelet therapy is 
only required for a period of 4 weeks, just enough time to 
improve the pulmonary function and make general   anesthesia 
Figure 1 Computed tomography of the severely calcified aorta.
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with mechanical ventilation possible. Together with the stent 
implantation, aortic valvuloplasty was performed. This pro-
cedure helped reduce pulmonary congestion, which improved 
pulmonary functions.
Conventional aortic valve replacement with cardiopulmo-
nary bypass under cardioplegic arrest is still the gold standard 
in the treatment of severe aortic valve stenosis and improves 
long-term survival compared to medical therapy.4
Without her comorbidities, our patient would have been 
a candidate for conventional open-heart surgery with aortic 
valve replacement (bioprosthesis) and coronary artery bypass 
grafting (CABG), as the literature shows that even in older 
patients this procedure can be performed with low morbidity 
and mortality.5,6 In our patient’s case, however, the logistic 
European System for Cardiac Operative Risk Evaluation 
predicted a mortality of 40% for the conventional surgical 
procedure. Furthermore, clamping of the extremely calcified 
aorta (Figure 1) would have posed a high risk for embolic 
stroke. Wound healing had to be considered in our patient 
because of her long-term steroid medication and osteoporosis. 
Regarding these last factors, the transapical approach with a 
lateral mini-thoracotomy was, in our opinion, much safer than 
a median sternotomy.
As the long-term results of valvuloplasty are poor7 and 
also inferior to transcatheter aortic valve implantation,8 
some sort of aortic valve replacement had to be performed 
thereafter, to resolve the symptoms of the patient and thus 
improve her quality of life. If the femoral vessels had been 
large enough (.6.5 mm in diameter for the Medtronic 
CoreValve delivery sheath which is 18 French) and free of 
calcifications, the transfemoral access would have been the 
method of choice because it can be performed without general 
anesthesia. If there are a lot of calcifications and the vessel is 
relatively small, as in our case, the risk for peripheral emboli 
could be reduced using the antegrade (transapical) access.9 
For all these reasons, we decided to perform a transapical 
aortic valve replacement.
Conclusion
A combination of modern interventional and minimally 
invasive surgical techniques to treat aortic valve stenosis and 
coronary heart disease can be a viable option for multimorbid 
patients with an extremely high risk for conventional open-
heart surgery. These procedures should then be carried out 
only in experienced centers with a hybrid-operating room and 
in a multidisciplinary approach where all kinds of complica-
tions, eg, dissection of the femoral vessels, stroke, rhythm 
disorders, etc, can be handled sufficiently. A cardiac surgeon 
and a heart-lung machine should always be on standby.
For most patients however, treatment of aortic valve 
stenosis with valve replacement under cardioplegic arrest 
remains the gold standard until the long-term durability of 
interventional valve prostheses is fully evaluated in prospec-
tive randomized trials.
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